ANI Pharmaceuticals, Inc. Share Price
NASDAQ: ANIPHealthcare
Live ANI Pharmaceuticals, Inc. Share Price Chart
O H L
ANI Pharmaceuticals, Inc. Performance Overview
Days Range
▼
$74.21Low
$75.50High
Markets Today
| Previous Close | $75.39 |
|---|---|
| Open | $75.50 |
| Volume | 59,154 |
| Day's Range | $74.21 - $75.50 |
| 52W Range | $69.58 - $98.55 |
| Market Cap | $1.69 B |
Historical Performance
| 1M Returns | -1.93 |
|---|---|
| 3M Returns | -5.16 |
| 6M Returns | +1.64 |
| 1Y Returns | -22.66 |
| 5Y Returns | +160.96 |
| 10Y Returns | +18.26 |
ANI Pharmaceuticals, Inc. Fundamentals
| Market Cap | $1.69 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 15.94 |
| PEG Ratio | N/A |
| Revenue | $883.37 M |
| ROE TTM | 0.15 |
| EPS TTM | $4.62 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.83 |
| EBITDA | $203.66 M |
| Profit Margin | 7.95 |
| Market Cap | $1.69 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 15.94 |
| PEG Ratio | N/A |
| Revenue | $883.37 M |
| ROE TTM | 0.15 |
| EPS TTM | $4.62 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.83 |
| EBITDA | $203.66 M |
| Profit Margin | 7.95 |
ANI Pharmaceuticals, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $197.12 M | $211.37 M | $227.81 M | $247.06 M | $237.46 M | $266.04 M |
| Gross Profit + | $124.08 M | $136.76 M | $134.42 M | $146.79 M | $143.88 M | $165.89 M |
| Operating Income | $26.19 M | $13.89 M | $36.53 M | $34.85 M | $38.89 M | $40.46 M |
| EBITDA | $49.09 M | $37.17 M | $59.93 M | $57.47 M | $59.81 M | $60.10 M |
| Interest Expense | $0 | -$5.44 M | $0 | -$20.06 M | $0 | -$3.64 M |
| Depreciation | $22.89 M | $23.28 M | $23.40 M | $22.61 M | $20.92 M | $19.64 M |
| Income Before Tax | $19.99 M | $10.53 M | $33.80 M | $31.48 M | $40.22 M | $37.10 M |
| Income Tax Expense | $4.31 M | $1.98 M | $7.18 M | $3.99 M | $10.73 M | $12.39 M |
| Net Income + | $15.68 M | $8.55 M | $26.62 M | $27.49 M | $29.49 M | $24.71 M |
| Net Profit Margin | 7.95% | 4.04% | 11.68% | 11.13% | 12.42% | 9.29% |
ANI Pharmaceuticals, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.00 K | $2.00 K | $3.00 K | $3.00 K | $3.00 K | $3.00 K |
| Reserve & Surplus | -$81.39 M | -$73.55 M | -$47.78 M | -$22.07 M | $6.87 M | $30.78 M |
| Non-Current Liabilities | $647.14 M | $644.56 M | $631.78 M | $621.54 M | $620.16 M | $613.25 M |
| Current Liabilities | $201.81 M | $236.84 M | $270.56 M | $278.11 M | $239.51 M | $283.65 M |
| Total Liabilities | $848.96 M | $881.39 M | $902.34 M | $899.65 M | $859.67 M | $896.90 M |
| Fixed Assets | $596.67 M | $579.57 M | $563.38 M | $542.00 M | $534.28 M | $523.08 M |
| Current Assets | $536.29 M | $602.63 M | $698.40 M | $753.12 M | $747.08 M | $825.43 M |
| Total Assets | $1.29 B | $1.34 B | $1.41 B | $1.44 B | $1.42 B | $1.49 B |
ANI Pharmaceuticals, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $15.68 M | $8.55 M | $26.62 M | $27.49 M | $29.49 M | $24.71 M |
| Operating Cash Flow | $34.99 M | $75.81 M | $44.05 M | $30.37 M | $58.38 M | $56.67 M |
| Investing Cash Flow | -$19.85 M | -$6.91 M | -$6.16 M | -$1.40 M | -$11.32 M | -$3.05 M |
| Financing Cash Flow | -$9.91 M | -$1.75 M | $6.34 M | -$4.64 M | -$21.62 M | -$4.65 M |
| Change in Cash | $4.94 M | $68.00 M | $44.81 M | $22.98 M | $25.59 M | $49.03 M |
ANI Pharmaceuticals, Inc. Return Calculator
The ANI Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$25,358
Invested Amount$10,000
Est. Returns$15,358
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Popular Stocks
FAQs
What is the share price of ANI Pharmaceuticals, Inc. today?
ANI Pharmaceuticals, Inc. (ANIP) share price as of September 18, 2026 is $73.26. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of ANI Pharmaceuticals, Inc.?
Yes, Indian Investors can invest in the ANI Pharmaceuticals, Inc. (ANIP) Share by opening an international trading account with Angel One.
How can I purchase ANI Pharmaceuticals, Inc. shares in India?
Purchasing ANI Pharmaceuticals, Inc. (ANIP) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying ANI Pharmaceuticals, Inc. (ANIP) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of ANI Pharmaceuticals, Inc.?
Yes, you can purchase fractional shares of ANI Pharmaceuticals, Inc. (ANIP) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of ANI Pharmaceuticals, Inc.?
The market capitalization of ANI Pharmaceuticals, Inc. on September 18, 2026, is $1.69 B.
In which sector ANI Pharmaceuticals, Inc. belongs?
ANI Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in ANI Pharmaceuticals, Inc. stocks?
In order to invest in ANI Pharmaceuticals, Inc. (ANIP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
